Keyword: Dilip Shanghvi

Pills

6. Sun Pharmaceutical Industries

India’s Sun Pharmaceutical has had its ambitions stymied by FDA action against a key manufacturing plant, but it still managed to generate more than $3.6 billion in generic sales last year.